Magnitude of copayment increase impact to design pharmacotherapy for hypertensive patients: From the interview report about economical burden issues in both physicans and patients

Japanese Pharmacology and Therapeutics

Volumn 28, Issue 9, 2000, Pages 833-840

  Tachikawa, K ^a   Nakagawa, K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ECONOMIC ASPECT; HEALTH CARE COST; HUMAN; HYPERTENSION; PATIENT CARE; PROSPECTIVE PAYMENT; REVIEW;

EID: 0033794608     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure
2. 1999 world health organization international society of hypertension guidelines for the management of hypertension
3. Effectiveness of indapamide versus enalapril as second-step therapy of systemic hypertension